PQNT0.290%
as of Oct 23
STE
GrowthSTERIS plc (Ireland)
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Close · 3M
+10.53%
Held by 2 AI ETFs
AIEQ0.060%
as of Oct 26
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals5
Win rate100% (5/5)
Avg buy return+8.72%
PQNT · Weight decrease · 2d
weight 0.310% → 0.290% (-0.020 pp)·stock down 6.9% in the 30 days before
Oct 9·entry $214.40·now $232.15
+8.28%
since Oct 9
PQNT · Weight increase · 2d
weight 0.290% → 0.320% (+0.030 pp)·stock down 9.4% in the 30 days before
Oct 5·entry $211.07·now $232.15Drifting
+9.99%
since Oct 5
PQNT · Weight increase · 2d
weight 0.290% → 0.310% (+0.020 pp)·stock down 1.7% in the 30 days before
May 21·entry $219.67·now $232.15Drifting
+5.68%
since May 21
AIEQ · New entry · 1d
weight 0 → 0.050% (new)·stock down 11.5% in the 30 days before
Oct 1·entry $209.34·now $232.15Chased
+10.90%
since Oct 1
AIEQ · Exit · 1d
weight 0.120% → 0 (exited)·stock up 0.6% in the 30 days before
Jul 1·entry $212.30·now $232.15
+9.35%
since Jul 1
AIEQ · New entry · 1d
weight 0 → 0.120% (new)·stock up 0.0% in the 30 days before
May 30·entry $211.07·now $232.15Drifting
+9.99%
since May 30
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.
Buffett-style framework
Fails the frameworkas of May 18
While one AI ETF (PQNT) holds a small position in STERIS, another (PQUS) recently exited, indicating mixed sentiment. This contrasts with the framework's 'Fail' verdict, which is primarily driven by the lack of a sufficient margin of safety at the current price.
- Circle of CompetenceThe medical devices sector, with its recurring revenue streams from consumables and services, generally allows for predictable unit economics over a ten-year horizon.
- Economic MoatSTERIS likely benefits from strong switching costs for healthcare providers due to integrated systems and regulatory requirements, as well as significant brand reputation and regulatory hurdles for competitors.
- ManagementManagement's candor, capital allocation discipline, and skin in the game cannot be assessed solely from the provided financial snapshot.
- Financial HealthThe single provided ROE of 10.21% is at the threshold, but without a 10-year average, operating margins, or debt details, a comprehensive assessment of financial health and owner earnings is not possible.
- Margin of SafetyThe company's high PER (29.39) and EV/EBITDA (24.29) multiples suggest a premium valuation, indicating an insufficient margin of safety for a conservative investment.
STERIS appears to operate within a predictable industry with a strong economic moat. However, the lack of comprehensive financial history and management insights, combined with an elevated valuation, leads to a 'Fail' verdict. The current price does not offer a margin of safety, making it unattractive despite its business quality.
Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.